Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Withdrawn 1Completed 1

Sponsor Class

OTHER 22INDUSTRY 2OTHER_GOV 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Classical hematology 21Breast 8Thoracic 2Other hematologic neoplasm 2Gastrointestinal 2Plasma cell 1Lymphoid 1Gynecologic 1Genitourinary 1

Conditions

Leukemia, Myeloid, Acute 879Leukemia, Lymphocytic, Chronic, B-Cell 560Leukemia 426Precursor Cell Lymphoblastic Leukemia-Lymphoma 331Hematologic Neoplasms 331Myelodysplastic Syndromes 302Leukemia, Myelogenous, Chronic, BCR-ABL Positive 244Lymphoma, Non-Hodgkin 224Recurrence 222Lymphoma 196Neoplasms 195Multiple Myeloma 129Lymphoma, Mantle-Cell 119Lymphoma, Large B-Cell, Diffuse 114Lymphoma, Follicular 114Leukemia, Myelomonocytic, Chronic 89Lymphoma, B-Cell 88Lymphoma, B-Cell, Marginal Zone 85Leukemia, B-Cell 79Burkitt Lymphoma 64Leukemia, Myeloid, Chronic-Phase 57Waldenstrom Macroglobulinemia 56Leukemia, Myeloid 53Hodgkin Disease 47Hematologic Diseases 47Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 45Myeloproliferative Disorders 40Primary Myelofibrosis 39Bronchiolitis Obliterans Syndrome 35Anemia, Refractory, with Excess of Blasts 32

Interventions

ceftolozane, tazobactam drug combination 1Itraconazole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
INDUSTRY × Febrile Neutropenia × Other hematologic neoplasm × Clear all
NCT05061654 2023-08-14

CEF-10

Hamad Medical Corporation

Phase 4 Withdrawn
Classical hematologyOther hematologic neoplasm

Hematologic Neoplasms, Febrile Neutropenia

NCT01706562 2013-02-20

A Study of Empirical Antifungal Therapy With Itraconazole

Janssen Korea, Ltd., Korea

Completed
138 enrolled
Classical hematologyOther hematologic neoplasm

Mycoses, Neutropenia, Hematologic Neoplasms, Febrile Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡